Securities Fraud Lawsuit Filed Against Alto Neuroscience, Inc.

Strategic Insights -

A class action securities lawsuit has been initiated against Alto Neuroscience, Inc. (NYSE: ANRO) on behalf of investors who allegedly suffered losses due to alleged securities fraud. The lawsuit, filed by Levi & Korsinsky, LLP, claims that the company's public statements were materially false and misleading. The case alleges that Alto's product pipeline, ALTO-100, was less effective in treating major depressive disorder than defendants had led investors to believe, and that the company's clinical, regulatory, and commercial prospects were overstated.

Key Takeaways:

  • The lawsuit seeks to recover losses on behalf of Alto Neuroscience, Inc. investors who purchased or acquired common stock and securities between February 2, 2024, and October 22, 2024.
  • The complaint alleges that defendants made false statements and/or concealed that Alto's product pipeline, ALTO-100, was less effective in treating major depressive disorder.
  • The lawsuit claims that Alto's business and/or financial prospects were overstated, and that the company's public statements were materially false and misleading.
  • The case involves allegations of securities fraud, and the company's alleged misrepresentations may have resulted in losses for investors.
  • Levi & Korsinsky is a securities litigation firm with extensive expertise in representing investors in complex securities litigation.

Statistics:

  • The lawsuit covers a period of approximately 8 months, from February 2, 2024, to October 22, 2024.
  • The class consists of all persons and entities that purchased or otherwise acquired Alto common stock and securities during this period.
  • The complaint alleges that Alto's product pipeline, ALTO-100, was less effective in treating major depressive disorder, which may have resulted in losses for investors.
  • The lawsuit seeks to recover losses on behalf of investors who suffered financial harm due to the alleged securities fraud.

Sources:

https://www.globenewswire.com/news-release/2025/09/16/2697360/0/en/Levi-Korsinsky-LLP-Notifies-Investors-of-Class-Action-Securities-Lawsuit-Against-Alto-Neuroscience-Inc-ANRO.html?feedid=10190